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Abstract
Background: Postural orthostatic tachycardia syndrome (POTS) is characterized by autonomic dysfunction
causing orthostatic intolerance. Psychiatrists should be aware of POTS because the symptoms exhibited by
patients, such as tachycardia, tremulousness, fatigue, and abdominal pain, may be misinterpreted as a primary
anxiety disorder, in particular panic disorder, or even as one of the somatoform disorders.
Objective: The authors review literature on POTS and highlight a case of a 23-year-old female with
hyperadrenergic POTS, admitted for a recurrent tachycardiac and hypertensive crisis.
Method: The authors present a case report of history, diagnosis, and treatment. After being treated in the
medical intensive care unit, the patient was referred to the internal medicine psychiatry service (med-psych) for
management because members of her medical team hoped her symptoms would be better treated by managing her
anxiety.
Results: The patient had a history of multiple referrals for anxiety in spite of a known diagnosis of POTS. She
also had serum catecholamines showing a normal norepinephrine while supine and comfortable, but highly elevated
during a tachycardiac and hypertensive crisis.
Conclusion: This case highlights the need for a broader understanding of POTS. Patients with this syndrome
have a primary autonomic dysfunction driving their symptoms, though anxiety can be a component. In addition,
serum catecholamines drawn while supine and comfortable may lead to inaccurate judgments as to the etiology of
the patients’ tachycardia and should only be interpreted in conjunction with catecholamines drawn while upright or
during an orthostatic crisis.

Keywords: Postural orthostatic tachycardia syndrome; Anxiety;
Norepinephrine, autonomic dysfunction

Introduction
Postural orthostatic tachycardia syndrome (POTS) is a condition of
autonomic dysfunction characterized by orthostatic intolerance
without orthostatic hypotension. Patients with this condition can
exhibit a variety of signs and symptoms, but the classic definition of
POTS is an increase in heart rate greater than 30 beats per minute in
the absence of hypotension within five minutes of assuming an upright
position in a symptomatic patient [1-3]. In addition to tachycardia or
palpitations, people with POTS can exhibit headaches, weakness,
abdominal pain, dizziness, fatigue, sweating, tremulousness, and
anxiety [2,3]. The symptoms associated with POTS are of particular
importance for psychiatrists to be aware of because providers may
overlook the overall symptom complex and focus only on the anxiety.
This may cause patients to be mislabeled as having a primary anxiety
disorder. This review begins with a case of a woman with POTS who,
due to her clinical presentation, was repeatedly referred to psychiatry
for management of her symptoms.
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Case
Ms. X is a 23-year-old Caucasian female with a history of
autonomic dysfunction, diagnosed as POTS. She has a history of
multiple emergency department visits and hospital admissions since
the age of 19 for symptoms associated with POTS, primarily episodes
of profound hypertension and tachycardia. She was taking tizanidine,
metoprolol, methyldopa, buccal fentanyl, and gabapentin as an
outpatient for management of hypertension, tachycardia, extremity
pain, and headache. She was also taking trazodone for insomnia,
ferrous sulfate for iron-deficiency anemia, and oral contraceptive pills.
Ms. X presented to the emergency department from a scheduled
cardiology visit after having a severe headache, flushing, palpitations,
burning leg pain, tachycardia with a heart rate in the 160s, and a
systolic blood pressure of 170. She was admitted to the medical
Intensive Care Unit (ICU), primarily for management of her
hypertension and tachycardia, and was placed on a labetolol
continuous infusion with intravenous (IV) hydromorphone as needed
for pain. While in the ICU, she had several episodes of tachycardia and
hypertension. During these episodes, Ms. X also complained of intense
burning pain in her extremities, usually her legs. She appeared restless
and anxious, and she was tremulous, writhing in the hospital bed due
to pain. Ms. X complained of hot flashes, and she would usually be
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flushed and sweating. Her episodes also had a diurnal variation,
usually having no symptoms in the morning with the episodes
primarily occurring in the late afternoon and evenings.
By hospital day number two, the patient’s hypertension,
tachycardia, and other symptoms resolved, and she was titrated off of
the labetolol infusion. Ms. X was deemed ready for transfer to a
general medicine bed. When deciding upon the accepting medicine
team, the combined medicine-psychiatry service was contacted to see
if they would accept the patient. Several physicians in the ICU were
concerned about Ms. X’s behavior, especially the restlessness and
writhing movements during the episodes. In fact, they felt some of the
behavior was inappropriate and extreme and hypothesized her
symptoms could be secondary to a primary anxiety disorder. They felt
that the med-psych service would be able to address her psychiatric
issues while continuing to manage any further hypertension or
tachycardia. Ms. X was transferred to the med-psych service in the
afternoon of hospital day two. In the evening on that same day, the
patient was sitting up in her room and again developed an episode of
tachycardia with hypertension and pain. She was treated with oral and
IV pushes of beta-blockers for blood pressure and heart rate control,
but her symptoms remained refractory to these methods. She was
transferred back to the medical ICU for management of hypertension
and tachycardia with labetolol infusion. Ms. X remained in the ICU for
three more days and was again titrated off of the infusion. On hospital
day six, she was stable without symptoms and discharged on her home
medications with the exceptions of scheduled propranolol for
hypertension, metoprolol only as needed for tachycardia, and
methadone for long-acting pain control. In addition, the patient’s
methyldopa was stopped due to ineffectiveness in controlling blood
pressure and to worsened mood.

When further examining Ms. X’s medical record and history during
the previous admissions, there was often debate between the medical
teams taking care of her and the psychiatry consult service or the medpsych service as to the underlying etiology of Ms. X’s clinical
presentation. The medical teams would see her behavior and often
insist that the patient was primarily anxious and that treating the
anxiety more effectively would improve her condition. The psychiatry
service would evaluate the patient and would acknowledge that she
appeared anxious during the episodes. However, they felt that the
extreme hypertension and tachycardia and overall symptom complex
could better be explained by POTS. Indeed, the diagnosis of POTS
itself was questioned by some medical teams because of certain
negative laboratory findings. Ms. X had an extensive workup in the
months prior, which included negative laboratory and imaging studies
for pheochromocytoma, carcinoid syndrome, hyperthyroidism,
Cushing’s disease, adrenal adenomas, or cardiac arrhythmias. She also
had an otherwise negative medical history. In order to diagnose POTS
as the cause of her episodes, fractionated catecholamines were drawn.
In fact, they were drawn on several occasions and varied widely. On
one occasion, Ms. X’s catecholamines were normal, and several people
on the medical teams cited this as evidence that the patient had no
hormonal or autonomic component involved in her presentation.
Thus, she must have a primary psychiatric illness rather than POTS.
Table 1 shows Ms. X’s fractionated catecholamines drawn on three
different occasions. During Times 1 and 3, the patient was in an acute
episode when the labs were drawn.

Time

Symptoms/vital signs

Time 1:

Burning leg pain, flushed, HR* 170, SBP** 1258 (7436)
180

222 (1212)

32 (209)

No symptoms; vital signs normal

<10

<10

529 (2888)

40 (261)

5 pm
Time 2:

Norepinephrine pg/mL (pmol/L)

81 (479)

Epinephrine
(pmol/L)

pg/mL Dopamine
(pmol/L)

pg/mL

10 am (8 months after
time 1)
Time 3:
5 pm (4 days after
Time 2)

Burning leg pain, flushed, tremulous, HR* 1618 (9564)
180, SBP** 250

Table 1: Fractionated plasma catecholamines in patient with POTS (*HR = heart rate **SBP = systolic blood pressure)

Literature Review and Case Discussion
Postural orthostatic tachycardia syndrome is a condition that is not
easy to diagnose, as patients have varying symptom presentations. In
general, POTS is characterized by functional hypovolemia when sitting
upright due to dysfunction of autonomic homeostatic blood pressure
control with changes in position [3]. Mainstays of treatment of most
patients with POTS are to increase salt and fluid intake to minimize
orthostatic decreases in venous return, encourage resistance exercises,
and offer medications. Fludrocortisone is often added to further
increase blood pressure and counteract the positional hypovolemia.
Beta-blockers are commonly used to control heart rate, and alpha-1agonists, like midodrine, are also utilized to increase vascular tone
[2,3]. Additional medications, which have been variously used for this
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condition, include pyridostigmine, clonidine, methyldopa,
Phenobarbital, and erythropoietin. The exact pathophysiology of
POTS is not fully understood, but several subtypes of POTS
(deconditioned POTS, neuropathic POTS, and hyperadrenergic
POTS) have been described based on proposed mechanisms [2]. All
three subtypes are characterized by orthostatic intolerance, but they
vary as to other signs. Although patients may exhibit signs of one or
more of these subtypes, each subtype has slightly different treatment
strategies [2,3].
In many cases, patients with POTS reduce their physical activity in
an effort to reduce symptoms. This can lead to deconditioning and
cause a cycle in which they become increasingly intolerant of exercise
or activity, leading to more and more severe symptoms with mild
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activity or positional changes [2]. This is known as deconditioned
POTS. In addition to the above treatments, a tailored and specific
exercise and rehabilitation program should be included in the
management strategy of this subtype.

Index, and also undergo the Structured Clinical Interview for DSM-IV
axis-I disorders (SCID) [6]. They found that patients with POTS had
no difference in prevalence of anxiety or depressive disorders
compared to the general population.

Neuropathic POTS is characterized by a restricted autonomic
neuropathy involving those post-ganglionic sympathetic neurons
having the longest axons (innervating the splanchnic bed and
extremities), the so-called length-dependent type. These patients
occasionally have antibodies to the ganglionic acetylcholine receptor
and will exhibit peripheral adrenergic failure due to denervation [2,3].
Patients with neuropathic POTS often respond to fludrocortisone and
an alpha-1-agonist like midodrine to increase vessel tone in addition
to volume expansion [2]. Acetylcholinesterase inhibitors like
pyridostigmine have been utilized in these patients, as well.

The above studies support the view that the tachycardia,
hypertension, and other symptoms in POTS are due to a diffuse and
peripheral autonomic dysfunction rather than solely on anxiety. As in
the case with Ms. X, POTS can be confused with anxiety or panic
attacks, but the primary team should be aware of the diagnosis so that
effective treatment is initiated, including agents like alpha-1 agonists
or fludrocortisone, instead of focusing only on anxiolytics.
Furthermore, understanding that the patient’s problem is orthostatic
intolerance rather than primary anxiety may help physicians to quickly
start a more comprehensive treatment regimen that includes betablockers, which improve symptoms and decrease orthostatic changes
in heart rate in patients with POTS [4]. Recognizing the distinctions
between primary panic attacks/anxiety and POTS may also help
psychiatrists on consult services when asked to see a patient with
unexplained tachycardia, hypertension, tremulousness, and anxiety.
The severity of tachycardia and hypertension in addition to an
association with postural changes can suggest POTS within the
differential diagnosis.

Hyperadrenergic POTS is a condition in which there is an excessive
release of norepinephrine with upright positional change. It is
characterized by blood pressure increases >10 mmHg and orthostatic
increases of plasma norepinephrine>600 pg/mL2 , or greater than three
times the supine level. Along with increased heart rate and blood
pressure, these patients have other signs of sympathetic activation
including tremulousness and anxiety. They may respond to abdominal
binders to reduce venous capacitance and non-selective betaantagonists like propranolol [2,4]. Acetylcholinesterase inhibitors may
also work in this group by increasing parasympathetic tone, thereby
mitigating the sympathetic over-activation. Alpha-2-agonists, like
clonidine, are commonly used for pressure control [3].
Overall, there are some interesting aspects of Ms. X’s case that
warrant further discussion. Given her increases in blood pressure and
serum catecholamines, it is most likely that she has the
hyperadrenergic subtype of POTS. As mentioned above, patients with
this type of POTS often have anxiety, a sign of sympathetic activation.
The interesting part of her case was the multiple discussions between
the psychiatric and medical services over several admissions about the
cause of her symptoms and the treatment required. Multiple internists
firmly held that anxiety or panic was driving the tachycardic and
hypertensive episodes. The psychiatric and med-psych teams insisted
that the patient had an autonomic dysfunction that was driving her
symptoms and that methods solely targeted to reduce anxiety would
have little benefit for her. They insisted that a more comprehensive
treatment for POTS would better treat her illness. Unfortunately,
patients with POTS are overly characterized as being anxious, and
their anxiety is viewed as the driving force rather than one component
of the overall illness [2,5]. Several studies have examined anxiety in
patients with POTS.
Masuki et al. sought to better understand the relationship between
POTS and anxiety [5]. In a group of fourteen patients with POTS and
ten healthy controls, all subjects underwent heart rate monitoring
during lower-body negative pressure (LBNP), simulating an
orthostatic increase in lower extremity venous pooling, and mental
arithmetic tests to represent an anxiety-provoking stimulus. Patients
with POTS had significantly higher heart rates with LBNP than
controls. However, there were no differences in heart rates between
groups during mental arithmetic tests, supporting the point that
physiologic changes in patients with POTS are not solely caused by
anxiety.
In another study, Raj et al. had patients with POTS complete
numerous questionnaires for psychiatric disorders, including the Beck
Depression Inventory, Beck Anxiety Inventory, and Anxiety Severity
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The second notable aspect of Ms. X’s case is the debate regarding
her serum catecholamines. She had fractionated catecholamines drawn
on several occasions, and on one occasion they were normal. Several
members of her multiple treating teams used the normal values to
support their view of a psychiatric diagnosis. However, the normal
values were observed when the patient was supine and asymptomatic.
This highlights the important point that fractionated catecholamines
should be drawn in patients with POTS in the setting of an orthostatic
positional change, or during an acute tachycardic episode. In fact, this
is one of the recommendations for diagnosing POTS [1,2]. Although
seeing a normal plasma norepinephrine while the patient is supine,
and not symptomatic, is important, this value can be misinterpreted if
not taken in the context of another plasma norepinephrine drawn at
the time of an orthostatic crisis. An elevated norepinephrine level
suggests, though is not diagnostic of, POTS, as it represents neuronal
spill over. A disproportionate elevation of epinephrine, which was not
observed in this patient, represents an adrenal secretory phenomenon,
as would more likely be evident with primary anxiety. Thus, providers
should be careful of the context in which they are drawing these
laboratory values. A broader understanding of the diagnostic criteria
for POTS can eliminate much confusion for both the physicians and
the patients.

Conclusion
This review focuses on postural orthostatic tachycardia syndrome
by highlighting the case of a 23-year-old female diagnosed with POTS
who presented to the emergency department with an episode of
tachycardia, hypertension, headache, tremulousness, and anxiety. She
required several days of IV labetolol for pressure control and was
eventually discharged home with two beta-blockers for blood pressure
and heart rate control in addition to tizanidine, gabapentin,
methadone, and as-needed fentanyl. Her case was notable for a history
of multiple referrals to psychiatry and the med-psych service for
management of anxiety in spite of her diagnosis of POTS. This case
highlights the importance for a broader understanding of POTS and
some of the frustrations and labels that patients with this disorder face.
Moreover, the diagnostic criteria for POTS based on plasma
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catecholamines should be more widely publicized. It is imperative that
norepinephrine be drawn both supine and after standing to look for
orthostatic changes. Recognizing the symptoms and diagnosis of
POTS may help decrease confusion between physicians regarding the
etiology of symptoms in this patient population.
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